| Entry |
|
| Name |
Istradefylline (JAN/USAN/INN)
|
| Formula |
C20H24N4O4
|
| Exact mass |
384.1798
|
| Mol weight |
384.429
|
| Structure |

     |
| Activity |
Treatment of the symptoms of Parkinson's disease [adenosine A2A receptor antagonist] [DS: H00057]
|
| Target |
adenosine A2a receptor antagonist [HSA: 135] [KO: K04266] |
| Pathway |
hsa04020 Calcium signaling pathway hsa04080 Neuroactive ligand-receptor interaction hsa04270 Vascular smooth muscle contraction | |
|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adenosine
adenosine A2a receptor [HSA:135] [KO:K04266]
Istradefylline
D04641 Istradefylline (JAN/USAN/INN)
 |
| Other DBs |
CAS: 155270-99-8 PubChem: LigandBox: |
| KCF data |
 ATOM 28
1 N4y N 14.8400 -16.6600
2 C8y C 14.8400 -18.0600
3 N4y N 13.6500 -18.7600
4 C8y C 12.3900 -18.0600
5 C8y C 12.3900 -16.6600
6 C8y C 13.6500 -15.9600
7 O5x O 13.6500 -14.5600
8 N4y N 11.0585 -16.2274
9 C8y C 10.2356 -17.3600
10 N5x N 11.0585 -18.4926
11 C1a C 10.6297 -14.9078
12 O5x O 16.0553 -18.7551
13 C1b C 13.6672 -20.1599
14 C1a C 14.8751 -20.8376
15 C1b C 16.0553 -15.9649
16 C1a C 17.2437 -16.6577
17 C2b C 8.8200 -17.3600
18 C2b C 8.1200 -16.1476
19 C8y C 6.7202 -16.1476
20 C8x C 6.0297 -14.9520
21 C8x C 4.6297 -14.9522
22 C8y C 3.9299 -16.1647
23 C8y C 4.6203 -17.3602
24 C8x C 6.0203 -17.3601
25 O2a O 2.5200 -16.1648
26 O2a O 3.9205 -18.5727
27 C1a C 2.5202 -18.5729
28 C1a C 1.8179 -17.3812
BOND 30
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 2
5 5 6 1
6 1 6 1
7 6 7 2
8 5 8 1
9 8 9 1
10 9 10 2
11 4 10 1
12 8 11 1
13 2 12 2
14 3 13 1
15 13 14 1
16 1 15 1
17 15 16 1
18 9 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 20 21 1
23 21 22 2
24 22 23 1
25 23 24 2
26 19 24 1
27 22 25 1
28 23 26 1
29 26 27 1
30 25 28 1
|